Affinage

RBM6

RNA-binding protein 6 · UniProt P78332

Length
1123 aa
Mass
128.6 kDa
Annotated
2026-06-10
13 papers in source corpus 8 papers cited in narrative 8 extracted findings
Cross-family judge faithfulness: 7/7 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

RBM6 is a nuclear RNA-binding protein that couples mRNA recognition to control of DNA double-strand break repair and chromatin-based transcriptional regulation (PMID:34718714, PMID:39344314). It contains two RNA recognition motifs that confer direct RNA-binding activity, originally shown by specific binding to poly(G) homopolymers (PMID:10353602), and genome-wide it engages a large set of mRNAs through preferential GGCGAUG and CUCU motifs, with targets enriched for proliferation- and apoptosis-associated genes whose alternative splicing depends on RBM6 (PMID:39344314). Within the nucleus RBM6 localizes to splicing speckles/interchromatin granule clusters and to nascent transcripts, with a repetitive N-terminal region that drives oligomerization and assembly of bead-like structures at the IGC periphery (PMID:21086038). RBM6 promotes homologous recombination repair through two separable activities: an alternative splicing-coupled nonstop-decay mechanism that maintains levels of the HR regulator Fe65/APBB1 (PMID:34718714), and a splicing-independent function in which its G-patch domain mediates recruitment to break sites and interaction with Rad51 to support Rad51 foci formation, with five G-patch glycine residues required for damage-site accumulation but dispensable for splicing (PMID:36941773). Consistent with this repair role, RBM6-deficient cancer cells are sensitized to ATM inhibition, PARP inhibition, and cisplatin (PMID:34718714). RBM6 additionally forms a complex with the deacetylase SIRT7 that lowers H3K18 acetylation at the OSX promoter to suppress osteogenic differentiation (PMID:33684230). A recurrent t(3;5) translocation fuses RBM6 to CSF1R, generating a constitutively active kinase fusion that drives myeloproliferative disease (PMID:17360941).

Mechanistic history

Synthesis pass · year-by-year structured walk · 8 steps
  1. 1999 Medium

    Establishing that RBM6 is a bona fide RNA-binding protein answered whether its RRM domains were functional, anchoring all later RNA-dependent models.

    Evidence In vitro RNA binding assay with recombinant protein containing the RRM domains

    PMID:10353602

    Open questions at the time
    • Binding to poly(G) homopolymers in vitro does not define physiological mRNA targets
    • No cellular function assigned at this stage
    • Single method, single lab
  2. 2007 High

    Identifying the RBM6-CSF1R fusion answered how a chromosomal translocation involving RBM6 contributes to leukemia, showing the fusion drives constitutive kinase signaling.

    Evidence 5'RACE fusion identification, IL-3-independent BaF3 growth assay, and murine transplant model

    PMID:17360941

    Open questions at the time
    • The oncogenic driver is CSF1R kinase activity, not native RBM6 function
    • Contribution of the RBM6 portion to fusion behavior not dissected
  3. 2010 Medium

    Mapping RBM6 to splicing speckles/IGCs and defining an N-terminal oligomerization domain answered where RBM6 acts in the nucleus and how it self-assembles on RNP structures.

    Evidence Immunostaining, tagged-protein expression, Xenopus lampbrush spreads, and deletion mapping

    PMID:21086038

    Open questions at the time
    • Functional consequence of oligomerization for splicing or repair not established
    • Molecular partners at IGCs not identified
  4. 2021 High

    Linking RBM6 to HR repair via splicing-coupled nonstop-decay of Fe65/APBB1 answered how an RNA-binding protein influences DNA repair and revealed a synthetic-lethal therapeutic vulnerability.

    Evidence Knockdown with splicing analysis, HR reporter assays, drug sensitivity tests, and mouse xenografts

    PMID:34718714

    Open questions at the time
    • Whether splicing regulation fully accounts for the HR phenotype was not resolved
    • Direct binding of RBM6 to the APBB1 transcript not shown in this study
  5. 2021 Medium

    Defining the RBM6-SIRT7 complex answered how RBM6 contributes to chromatin regulation, showing it directs histone deacetylation to a developmental gene promoter.

    Evidence Co-immunoprecipitation, ChIP for H3K18Ac at the OSX promoter, knockdown, and in vivo osteogenesis assay

    PMID:33684230

    Open questions at the time
    • Whether RBM6 recruitment to OSX depends on its RNA-binding activity is unknown
    • Co-IP without reciprocal/structural validation of the complex interface
  6. 2023 High

    Dissecting the G-patch domain answered whether RBM6 has a repair role beyond splicing, separating a splicing-independent Rad51-recruitment function from its splicing activity.

    Evidence Domain mutagenesis, live-cell DSB recruitment imaging, Rad51 Co-IP and foci quantification, and HR reporter assays

    PMID:36941773

    Open questions at the time
    • How PARP1 indirectly governs RBM6 recruitment is unresolved
    • Structural basis of the G-patch-Rad51 interaction not determined
  7. 2024 Medium

    Genome-wide iRIP-seq answered which transcripts RBM6 binds directly and defined its sequence preferences, connecting binding to splicing of proliferation/apoptosis genes.

    Evidence iRIP-seq in HeLa cells with transcriptome sequencing after knockdown

    PMID:39344314

    Open questions at the time
    • Which bound transcripts are functionally regulated versus passively bound not resolved
    • Motif preference not validated by mutagenesis
  8. 2025 Low

    Examining migration genes in prostate cancer addressed whether RBM6's regulatory output is fixed, showing it is context-dependent on ZEB1 levels.

    Evidence Migration assays, RNA pulldown, and RNA immunoprecipitation in prostate cancer cells

    PMID:39900560

    Open questions at the time
    • Single lab, single paper, context-specific with limited mechanistic pathway placement
    • How ZEB1 switches RBM6 target preference is unexplained
    • Direct splicing versus expression mechanism on CDH1/MMP16 not distinguished

Open questions

Synthesis pass · forward-looking unresolved questions
  • How RBM6's RNA-binding, oligomerization, splicing, and direct Rad51-recruitment activities are coordinated into a single regulatory program remains unresolved.
  • No structural model integrating RRM, N-terminal oligomerization, and G-patch domains
  • Mechanism linking PARP1 activity to RBM6 recruitment unknown
  • Whether IGC localization is required for repair or splicing functions untested

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0003723 RNA binding 2
Localization
GO:0005634 nucleus 1 GO:0005654 nucleoplasm 1
Pathway
R-HSA-73894 DNA Repair 2 R-HSA-8953854 Metabolism of RNA 2

Evidence

Reading pass · 8 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
1999 RBM6 (DEF-3/NY-LU-12) encodes an RNA-binding protein containing two RNA recognition motifs (RRMs); recombinant proteins containing the RRMs of RBM6 specifically bound poly(G) RNA homopolymers in vitro, demonstrating direct RNA-binding activity. In vitro RNA binding assay with recombinant protein containing RRM domains Oncogene Medium 10353602
2007 RBM6 forms a fusion protein with CSF1R (via t(3;5)(p21;q33) translocation) in acute megakaryoblastic leukemia; the RBM6-CSF1R fusion protein confers IL-3-independent growth in BaF3 cells and induces myeloproliferative disease in a murine transplant model, demonstrating constitutive kinase activation driven by the fusion. 5'RACE cDNA sequencing to identify fusion; BaF3 functional growth assay; murine transplant model Blood High 17360941
2010 RBM6 localizes to splicing speckles/interchromatin granule clusters (IGCs) and to nascent transcripts on lampbrush chromosomes. The repetitive N-terminal region of RBM6 acts as a multimerization/oligomerization domain required for assembly of novel bead-like structures on the IGC surface; without this domain, RBM6 accumulates homogeneously within IGCs rather than at their periphery. Oligomerized RBM6 on lampbrush loops causes them to appear as dense spiral structures distinct from normal extended loops. Immunostaining of endogenous RBM6 in mammalian cell lines; tagged RBM6 expression; Xenopus oocyte germinal vesicle spread preparations; deletion mapping of oligomerization domain Chromosome Research Medium 21086038
2021 RBM6 promotes homologous recombination (HR) repair of DNA double-strand breaks (DSBs) by regulating alternative splicing-coupled nonstop-decay of the HR regulator Fe65/APBB1; RBM6 knockdown severely reduces Fe65 protein levels and impairs HR. RBM6-deficient cancer cells show increased sensitivity to ATM inhibition, PARP inhibition, and cisplatin. RBM6 knockdown; alternative splicing analysis; HR reporter assays; drug sensitivity assays; mouse xenograft model Nucleic Acids Research High 34718714
2021 RBM6 forms a protein complex with the histone deacetylase SIRT7; this complex downregulates H3K18 acetylation at the OSX promoter by recruiting SIRT7 to it, thereby inhibiting expression of OSX isoforms 1 and 2 and suppressing osteogenic differentiation of mesenchymal stem cells. Co-immunoprecipitation (complex formation); ChIP (H3K18Ac at OSX promoter); RBM6 knockdown; in vivo osteogenesis assay Stem Cells Medium 33684230
2023 RBM6 is recruited to DSB sites in a manner indirectly regulated by PARP1 activity. Five glycine residues within the G-patch domain are required for RBM6 accumulation at DNA damage sites but are dispensable for its splicing activity (no effect on Fe65 or Eya2 splicing targets). RBM6 interacts with Rad51 via its G-patch domain; deletion of this domain attenuates Rad51 interaction and reduces Rad51 foci formation after ionizing radiation, impairing HR repair independently of splicing. Deletion mapping with domain mutants; live-cell imaging of DSB recruitment; Co-IP of RBM6 with Rad51; Rad51 foci quantification after IR; HR reporter assay Molecular and Cellular Biology High 36941773
2024 iRIP-seq analysis in HeLa cells revealed that RBM6 directly interacts with a large number of mRNAs, with preferential binding motifs GGCGAUG and CUCU, enriched for mRNAs of cell proliferation- and apoptosis-associated genes that undergo altered alternative splicing upon RBM6 knockdown. Improved RNA immunoprecipitation coupled with sequencing (iRIP-seq); whole transcriptome sequencing after shRBM6 knockdown Frontiers in Bioscience Medium 39344314
2025 In prostate cancer cells, RBM6 suppresses CDH1 expression to promote cell migration, but when ZEB1 is overexpressed, RBM6 instead inhibits MMP16, shifting its net effect to reduced migration. RNA pulldown and RNA immunoprecipitation confirmed RBM6 binding to target mRNAs. Thus RBM6's regulatory output on migration-related genes is context-dependent on ZEB1 levels. Scratch/transwell migration assays; PCR and western blot; RNA pulldown; RNA immunoprecipitation Journal of Cellular and Molecular Medicine Low 39900560

Source papers

Stage 0 corpus · 13 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
1999 DEF-3(g16/NY-LU-12), an RNA binding protein from the 3p21.3 homozygous deletion region in SCLC. Oncogene 41 10353602
2007 A novel fusion of RBM6 to CSF1R in acute megakaryoblastic leukemia. Blood 38 17360941
2007 RBM6-RBM5 transcription-induced chimeras are differentially expressed in tumours. BMC genomics 32 17908320
2021 RBM6 splicing factor promotes homologous recombination repair of double-strand breaks and modulates sensitivity to chemotherapeutic drugs. Nucleic acids research 31 34718714
2019 RNA-binding protein RBM6 as a tumor suppressor gene represses the growth and progression in laryngocarcinoma. Gene 25 30772516
2021 LncRNA, PLXDC2-OT promoted the osteogenesis potentials of MSCs by inhibiting the deacetylation function of RBM6/SIRT7 complex and OSX specific isoform. Stem cells (Dayton, Ohio) 21 33684230
2000 Targeting of endothelial KDR receptors with 3G2 immunoliposomes in vitro. Biochimica et biophysica acta 21 10825432
2023 Spindle cell rhabdomyosarcomas: With TFCP2 rearrangements, and novel EWSR1::ZBTB41 and PLOD2::RBM6 gene fusions. A study of five cases and review of the literature. Histopathology 14 38114270
2010 Subnuclear targeting of the RNA-binding motif protein RBM6 to splicing speckles and nascent transcripts. Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology 10 21086038
2023 Recruitment of RBM6 to DNA Double-Strand Breaks Fosters Homologous Recombination Repair. Molecular and cellular biology 6 36941773
2021 RNA-binding protein RBM6 acts as a tumor suppressor gene to inhibit the progression of hepatocellular carcinoma. Journal of B.U.ON. : official journal of the Balkan Union of Oncology 3 34076986
2025 The Oncopromoting Gene RBM6 Inhibits Prostate Tumour Cell Migration During Epithelial-to-Mesenchymal Transition. Journal of cellular and molecular medicine 1 39900560
2024 Global RNA Interaction and Transcriptome Profiles Demonstrate the Potential Anti-Oncogenic Targets and Pathways of RBM6 in HeLa Cells. Frontiers in bioscience (Landmark edition) 1 39344314

Missed literature

Know a paper Affinage missed for RBM6? Flag it for the maintainers and the community.

No submissions yet.